Parties d'ouvrages collectifs (1)

  1. 1. Vachiery, J.-L. (2012). Atrial septostomy. In Pulmonary Vascular Disorders (pp. 254-261). S. Karger AG. doi:10.1159/000336119
  2.   Articles dans des revues avec comité de lecture (133)

  3. 1. Rothman, A. A., Vachiery, J.-L., Howard, L., Mikhail, G. G., Lang, I., Jonas, M., Kiely, D. G., Shav, D., Shabtay, O., Avriel, A., Lewis, G. D., Rosenzweig, E. E., Kirtane, A. J., Kim, N. H., Mahmud, E., McLaughlain, V. V., Chetcuti, S., Leon, M. M., Ben-Yehuda, O., & Rubin, L. (2020). Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study. J A C C: Cardiovascular Interventions, 13(8), 989-999. doi:10.1016/j.jcin.2019.12.027
  4. 2. Vachiery, J.-L., & Galie, N. (2019). Beyond the World Symposium on Pulmonary Hypertension: practical management of pulmonary arterial hypertension and evolving concepts. European heart journal supplements, 21, K1-K3. doi:10.1093/eurheartj/suz209
  5. 3. McLaughlin, V., Vachiery, J.-L., Oudiz, R. J., Rosenkranz, S., Galie, N., Barbera, J. A., Frost, A., Ghofrani, H. A., Peacock, A., Simonneau, G., Rubin, L., Blair, C., Langley, J., & Hoeper, M. M. (2019). Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial. The Journal of heart and lung transplantation, 38(12), 1286-1295. doi:10.1016/j.healun.2019.09.010
  6. 4. Vachiery, J.-L., Galie, N., Barbera, J. A., Frost, A., Ghofrani, H. A., Hoeper, M. M., McLaughlin, V., Peacock, A., Simonneau, G., Blair, C., Miller, K. K., Langley, J., & Rubin, L. (2019). Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial. The Journal of heart and lung transplantation, 38(2), 194-202. doi:10.1016/j.healun.2018.11.006
  7. 5. Gall, H., Vachiery, J.-L., Tanabe, N., Halank, M., Orozco-Levi, M., Mielniczuk, L., Chang, M., Vogtländer, K., & Grünig, E. (2018). Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH. Lung, 196(3), 305-312. doi:10.1007/s00408-018-0112-z
  8. 6. Caravita, S., Dewachter, C., Soranna, D., D'Araujo, S. C., Khaldi, A., Zambon, A., Parati, G., Bondue, A., & Vachiery, J.-L. (2018). Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis. The European respiratory journal, 51(4). doi:10.1183/13993003.02427-2017
  9. 7. Vachiery, J.-L., Delcroix, M., Al Hiti, H., Efficace, M., Hutyra, M., Lack, G., Papadakis, K., & Rubin, L. (2018). Macitentan in pulmonary hypertension due to left ventricular dysfunction. The European respiratory journal, 51(2). doi:10.1183/13993003.01886-2017
  10. 8. Caravita, S., Faini, A., Carolino D'Araujo, S., Dewachter, C., Chomette, L., Bondue, A., Naeije, R., Parati, G., & Vachiery, J.-L. (2018). Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component. PloS one, 13(6), e0199164. doi:10.1371/journal.pone.0199164
  11. 9. Royer, P. J., Antoine, M., Cappello, M., Souilamas, R., Ruiz, M., Sokolow, Y., Vanden Eynden, F., Van Nooten, G., Barvais, L., Berré, J., Brimioulle, S., De Backer, D., Creteur, J., Engelman, E., Huybrechts, I., Ickx, B., Preiser, T., Tuna, T., Van Obbergh, L., Vancutsem, N., Vincent, J. L., De Vuyst, P., Etienne, I., Féry, F., Jacobs, F., Knoop, C., Vachiery, J.-L., Van den Borne, P., Wellemans, I., Amand, G., Collignon, L., Giroux, M., et al. (2017). TLR3 promotes MMP-9 production in primary human airway epithelial cells through Wnt/β-catenin signaling. Respiratory research, 18(1), 208. doi:10.1186/s12931-017-0690-y
  12. 10. McLaughlin, V., Pulido, T., Pepke-Zaba, J., Barberà, J. A., Hoeper, M. M., Vachiery, J.-L., Lang, I., Carvalho, F., Meier, C., Mueller, K., Nikkho, S., Jansa, P., D'Armini, A. M. A. A., Nielsen-Kudsk, J. E., Halank, M., Simonneau, G., Grünig, E., Ulrich, S., Rosenkranz, S., & Gomez Sanchez, M. A. (2017). Riociguat in patients with chronic thromboembolic pulmonary hypertension: Results from an early access study. BMC pulmonary medicine, 17(1), 216. doi:10.1186/s12890-017-0563-7
  13. 11. Hoeper, M. M., Dorfmuller, P., Guazzi, M., Galie, N., Manes, A., Handoko, M. L., Vonk-Noordegraaf, A., Lankeit, M., Konstantinides, S., Wachter, R., Opitz, C., Lam, C. C., Rosenkranz, S., Vachiery, J.-L., Bauersachs, J., Gerges, C., Lang, I., Bonderman, D., Olsson, K. K., & Gibbs, J. S. R. J. (2017). Pulmonary hypertension in heart failure with preserved ejection fraction: A plea for proper phenotyping and further research. European heart journal, 38(38), 2869-2873. doi:10.1093/eurheartj/ehw597

  14. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Suivant >>